Clinical Trial Update: Safety and Efficacy Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction.Infarction [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing safety and efficacy of Thymosin Beta 4 in patients with acute myocardial infarction has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Thymosin beta-4 (thymosin beta-4)

Snippet

Sponsor: Beijing Northland Biotech. Co., Ltd. | Conditions: Acute Myocardial Infarction | Phase 2 | Status: COMPLETED